US Pharma Giant Raises $9B to Acquire Centessa
Eli Lilly has secured $9 billion in financing to acquire Centessa, a clinical-stage biotechnology firm specializing in sleep disorders and gene therapy. This strategic acquisition aims to accelerate the development ... Read More